The intellectual property and technology transaction team at Paul, Weiss, Rifkind, Wharton & Garrison LLP handles the full spectrum of intellectual property licensing and transactional matters, ranging from standalone transactions to cross-border mergers and acquisitions across the life sciences and technology industries. New York-based Claudine Meredith-Goujon acts as global co-head of the intellectual property and technology transactions team and has advised complex IP licenses and transactions for large consumer products and luxury brands. Jeffrey Osterman is another key name in the team with a strong focus on the life sciences space.

The intellectual property attorneys at DLA Piper LLP (US) have developed a robust patent licensing practice, strategizing with clients of all sizes, from emerging companies to multinational corporations in the life sciences and technology industries, on a range of complex matters, including patent licensing, patent asset management, and acquisitions and sales. In Boston, Larissa Bifano leads the firm’s patent development and strategy practice and advises US and international innovators in the energy, healthcare, and artificial intelligence sectors on intellectual property strategy. Philadelphia-based Raymond Miller chairs the life sciences patent development and strategy practice, leveraging his life and material sciences expertise to counsel clients on freedom-to-operate, regulatory exclusivity, and trade secret matters. In San Diego, Lisa Haile concentrates on FDA counseling, due diligence, and transactional matters for life sciences clients. In Palo Alto, Victoria Lee is dedicated to drafting and negotiating patent license agreements on behalf of major technology clients.

Headquartered in Boston, the intellectual property transactions services team at Goodwin advises early-stage companies, established businesses, and academic institutions in establishing licensing frameworks, collaboration agreements, and business transactions. The intellectual property group is co-chaired by Boston-based Catherine McCarthy, who represents public and private companies, as well as venture capital partnerships in the pharmaceutical, life sciences, and technology industries, and Silicon Valley-based James Riley, who strategizes with emerging technology companies on licensing, commercialization, and investments. Other key members of the team include Boston-based life sciences co-chair Kingsley Taft, who focuses on commercial transactions, M&A, and IPOs, and DC-based Noelle Dubiansky, who offers strategic licensing and transactional advice to biotechnology, pharmaceutical, and medical device clients.

Headquartered in Los Angeles, the team at Latham & Watkins is well-positioned to handle a broad range of complex IP transactions, cross-licensing, and collaboration matters, with deep specialism and global footprint in technology and life sciences. The firm’s healthcare and life sciences licensing practice is led by San Diego-based Steven Chinowsky, who represents key biopharmaceutical companies in global licensing and development agreements, as well as in corporate transactions. Other key team members include New York-based Aaron Gardner, who focuses on mergers and acquisitions and licensing transactions for clients across the life sciences industry, and San Francisco-based Kate Hillier, who focuses on the discovery, development, and marketing of biopharmaceuticals, vaccines, and medical devices.

Headquartered in New York, the technology and IP transactions department at Weil, Gotshal & Manges LLP is dedicated to engaging in sophisticated IP transactions involving technology and data innovations, including acquisitions, dispositions, joint ventures, licensing agreements, and outsourcing agreements. The practice group operates under the leadership of Charan Sandhu in New York, who concentrates on the development, acquisition, and commercialization of technology-related IP on behalf of established businesses. Also based in New York is Olivia Greer, head of the US private and cybersecurity practice, who focuses on cross-border transactions and evaluates cybersecurity risk in mergers and acquisitions and investments, and Dennis Adams, who advises high-value acquisitions and licensing agreements for technology clients.

Headquartered in New York, the Intellectual Property team at Cleary Gottlieb Steen & Hamilton has expertise in patent licensing, strategic alliances, and IP due diligence in cross-border corporate and financing transactions, with experience working alongside sophisticated technology and pharmaceutical companies. The team’s efforts are spearheaded by New York-based Daniel Ilan and San Francisco-based Marcela Robledo. Ilan focuses on technology and AI transactions on behalf of multinational technology companies and private equity firms, while advising clients on transaction-related cybersecurity and privacy issues. Robledo is also a specialist in technology transactions, handling IP, data, and technology in mergers and acquisitions, licensing, and collaboration agreements.

Davis Polk & Wardwell LLP has a sophisticated IP and commercial transactions team that regularly represents multinational corporations across the life sciences, hospitality, and transportation industries in IP-driven transactions and commercial agreements. The team operates under the leadership of New York-based Frank Azzopardi, an expert in structuring commercial and licensing agreements to maximize asset value, with clients spanning consumer products, media, and airlines. Other key members of the New York team include Pritesh Shah, who specializes in IP transactions related to technology, mobile apps, and data monetization; Matthew Bacal, who focuses on complex commercial agreements and copyright issues; and David Bauer, who has extensive experience representing life sciences clients in IP-related corporate and commercial transactions, such as those involving gene therapies and small molecule pharmaceuticals.

Headquartered in Silicon Valley, the technology transactions team at Fenwick & West LLP has extensive experience in IP licensing and transactions involving a variety of cutting-edge technologies, including IP audits, research institute licensing, and negotiations. The intellectual property team is led by San Francisco-based Jennifer Stanley, who advises leading consumer technology, gaming, and entertainment companies on transactions, copyright, and business licensing matters. Assisting Stanley are Silicon Valley-based David Hayes, who specializes in technology development, licensing, and distribution, and San Francisco-based Joseph Schenck, who focuses on IP transactions involving software, SaaS, and other technologies.

Kirkland & Ellis LLP, headquartered in Chicago, has a well-established technology and IP transactions team dedicated to handling patent licensing negotiations and agreements. The team’s expertise spans a broad range of disciplines, from electrical engineering and computer science to molecular genetics and environmental science. Key members of the team include Chicago-based Seth Traxler, who leads IP-driven mergers and acquisitions, financings, and licenses; New York-based David MacDonald, who focuses on pharmaceutical and biotechnology licenses, distributions, and collaborations; and Chicago-based Russell Levine, who is experienced in structuring and negotiating complex licensing transactions.

Operating out of San Francisco, the intellectual property team at Morrison Foerster has extensive experience in customized IP strategy across the IP lifecycle, from patent applications to complex licensing, advertising, and transactional matters, with a specialist focus on the technology industry. Aaron Rubin chairs the firm’s interactive and digital media group from the firm’s headquarters and leads complex IP and technology transactions, including strategic licensing and distribution deals. Also based in San Francisco is Justin Haan, chair of the technology transactions practice, who focuses his practice on IP and technology-related licensing agreements and commercial agreements, with a specialty in open-source software. Another key member of the team is San Francisco-based Tessa Schwartz, who advises on key patent licenses and acquisitions, joint ventures, and collaborations for advanced technologies, such as machine learning, SaaS, and consumer electronics.

Baker Botts L.L.P. provides comprehensive support across the full lifecycle of intellectual property, specializing in the development, protection, and commercialization of proprietary technologies. The firm is adept at navigating the intersection of IP law and commercial transactions, frequently handling complex multiparty licensing, technology transfers, and international outsourcing agreements. Its expertise extends to high-stakes M&A, where the team conducts sophisticated IP due diligence for both acquirers and targets across various tech sectors. The practice is distinguished by its ability to translate technical innovation into maximized value for IP portfolios through strategic business counseling and litigation. The department is led by Dallas-based firm chair Christa Brown-Sanford, who is noted for her patent procurement and licensing expertise for clients including Cisco and Toyota. In New York, deputy chair Jennifer Tempesta and IP transactions co-chair Paul Ragusa are key contacts; Ragusa is particularly recognized for his work on standard-essential patents (SEPs). DC-based co-chair Luke Pedersen rounds out the leadership, focusing on emerging technology transfers.

Headquartered in Cleveland, BakerHostetler has a sophisticated IP and technology transactions and outsourcing team, focused on the licensing of assets while also identifying new business opportunities in the market. The team also handles out-licensing of technology patent deals for educational institutions and evaluates IP matters during mergers and acquisitions. Key members of the team include Cleveland-based Monica Verma, who negotiates technology contracts for insurance, manufacturing, and healthcare services clients; Philadelphia-based Chad Rutkowski, who advises clients on IP monetization and software and AI-related issues; and Atlanta-based Christopher Arena, who has extensive knowledge on a broad spectrum of IP matters and strategic transactions.

With headquarters in Detroit, the IP licensing and transactions team at Dickinson Wright PLLC is well-positioned to handle software licensing, technology licensing for educational institutions, and cross-licensing during disputes, as well as counseling clients in the data, manufacturing, and automotive industries on licensing matters throughout the business lifecycle. Richard Jones leads the team from the firm’s Troy office and negotiates patent license agreements for domestic and international clients in the mechanical and electrical technology industries. Supporting Jones is Austin-based Lance Anderson, who leverages his past in-house counsel experience when preparing and negotiating patent license agreements and IP-related transactions.

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is headquartered in Washington DC, and has a well-established technology transactions department dedicated to licensing programs, strategic alliances, and other IP transactions and acquisitions. The technology transaction team operates under the leadership of Brian Kacedon in the firm’s headquarters, who has extensive experience leading IP transactions and complex license agreements for clients across the pharmaceutical, medical device, software, and consumer electronics industries. Supporting Kacedon are Boston-based Nishla Keiser, who leads IP diligence and patent license agreements in major corporate transactions, and Atlanta-based Virginia L. Carron, who counsels several Fortune 500 companies on trademark and patent licensing matters.

Headquartered in Boston, the licensing and strategic transactions team at Foley Hoag LLP is well-equipped to handle complex licensing arrangements across the healthcare and life sciences industries. The team also represents academic institutions and global companies on licensing and collaboration matters, advising on leading innovations in highly regulated markets. The team operates under the joint leadership of Boston-based Sarah Cooleybeck, who leads cross-border transactions and license agreements in the oncology, antibody, and pharmaceutical sectors; Boston-based John Harre, who works on drafting and executing complex mergers and acquisitions and licensing agreements in the life sciences, technology, and energy industries; and New York-based Sumantha Sedor, who advises leading life sciences companies from discovery through to commercialization.

The patent licensing and transactions team at Knobbe Martens Olson & Bear LLP is dedicated to providing counsel to clients across the life sciences, biotechnology, electrical engineering, and software industries on a range of matters, including negotiating patent licensing, transfer agreements, and high-stakes patent settlements. Based in Irvine, Salima Merani, Ph.D., co-chairs the firm’s medical device practice and has an extensive patent-focused practice, including experience as lead counsel in high-value IP transactions for US and international patent portfolios. Also in Irvine, Sabing Lee supports Merani as co-chair of the medical devices practice and focuses on IP due diligence, strategic counseling, and licensing matters for a range of technologies. Based in San Diego, former aerospace engineer Tom Cowan advises aerospace and medical device technologies in IP audits, trade secret protections, license negotiations, and infringement investigations.